GLP1R and type 2 diabetes mellitus: Many studies have demonstrated that overweight or obese people with type 2 diabetes have a better tolerance to the GLP-1 receptor agonist liraglutide, which can reduce food intake without increasing energy consumption, to achieve a good weight loss goal [9, 10].